Claims for Patent: 5,763,407
✉ Email this page to a colleague
Summary for Patent: 5,763,407
| Title: | High-purity desmopressin produced in large single batches |
| Abstract: | A process for the manufacture of high purity desmopressin produced in single batches of substantial size and a method of treating diabetes insipidus with the high purity desmopressin produced therefrom. |
| Inventor(s): | Larsson; Krister (Malmo, SE), Mellbrand; Thomas (Malmo, SE), Mornstam; Birgitta (Bunkeflostrand, SE), Roschester; Jan (Lund, SE), Skoldback; Jan-Ake (Malmo, SE) |
| Assignee: | Ferring BV (Hoofddorp, NL) |
| Application Number: | 08/797,826 |
| Patent Claims: |
1. A method for treating diabetes insipidus, hemophilia A and von Willebrand's disease, comprising oral, nasal or intravenous administration of a dose of desmopressin
effective to produce a physiological effect, said desmopressin produced in a single batch having a weight of at least about 50 g containing at least 98.5% by weight of desmopressin (C.sub.46 H.sub.64 N.sub.14 O.sub.12 S.sub.2) in respect of adjoining
matter other than water and acetic acid, said batch produced with a final synthetic step in which at least about 1 kg of mercapto-propionyl-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH.sub.2 (SEQ ID NO: 2) or a derivative thereof, said derivative being stable at
neutral or slightly acidic conditions, is dissolved in a protic solvent at neutral or slightly acidic conditions to form a reactant solution into which a second solution of iodine in a protic solvent or solvent mixture is introduced under agitation to
form a reactant/reagent solution in which desmopressin is being formed.
2. A single oral dose of desmopressin effective to produce a physiological effect for treatment of diabetes insipidus, hemophilia A and von Willebrand's disease, said dose prepared from a desmopressin batch produced in single batches of desmopressin having a weight of at least about 500 g containing at least 98.5% by weight of desmopressin (C.sub.46 H.sub.64 N.sub.14 O.sub.12 S.sub.2) in respect of adjoining matter other than water and acetic acid, said batches produced with a final synthetic step, in which at least about 1 kg of mercapto-propionyl-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH.sub.2 (SEQ ID NO: 2) or a derivative thereof, said derivative being stable at neutral or slightly acidic conditions, is dissolved in a protic solvent at neutral or slightly acidic conditions to form a reactant solution into which a second solution of iodine in a protic solvent or solvent mixture is introduced under agitation to form a reactant/reagent solution in which desmopressin is being formed. 3. A single oral dose of desmopressin effective to produce a physiological effect for treatment of diabetes insipidus, hemophilia A and von Willebrand's disease, said dose prepared from a single batch of desmopressin containing no less than 44 g of desmopressin (C.sub.46 (H.sub.64 N.sub.14 O.sub.12 S.sub.2) and no more than a total of 1.5% by weight of adjoining matter with respect to desmopressin (C.sub.46 H.sub.64 N.sub.14 O.sub.12 S.sub.2) other than water and acetic acid. |
